175 related articles for article (PubMed ID: 34480014)
21. Antidepressant-like effects of ketamine in a mouse model of serotonergic dysfunction.
Wilson C; Li S; Hannan AJ; Renoir T
Neuropharmacology; 2020 May; 168():107998. PubMed ID: 32061666
[TBL] [Abstract][Full Text] [Related]
22. Essential roles of neuropeptide VGF regulated TrkB/mTOR/BICC1 signaling and phosphorylation of AMPA receptor subunit GluA1 in the rapid antidepressant-like actions of ketamine in mice.
Shen M; Lv D; Liu X; Li S; Chen Y; Zhang Y; Wang Z; Wang C
Brain Res Bull; 2018 Oct; 143():58-65. PubMed ID: 30316917
[TBL] [Abstract][Full Text] [Related]
23. miR-9-5p is involved in the rescue of stress-dependent dendritic shortening of hippocampal pyramidal neurons induced by acute antidepressant treatment with ketamine.
Mingardi J; La Via L; Tornese P; Carini G; Trontti K; Seguini M; Tardito D; Bono F; Fiorentini C; Elia L; Hovatta I; Popoli M; Musazzi L; Barbon A
Neurobiol Stress; 2021 Nov; 15():100381. PubMed ID: 34458512
[TBL] [Abstract][Full Text] [Related]
24. Prophylactic Ketamine Treatment Promotes Resilience to Chronic Stress and Accelerates Recovery: Correlation with Changes in Synaptic Plasticity in the CA3 Subregion of the Hippocampus.
Krzystyniak A; Baczynska E; Magnowska M; Antoniuk S; Roszkowska M; Zareba-Koziol M; Das N; Basu S; Pikula M; Wlodarczyk J
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30965559
[TBL] [Abstract][Full Text] [Related]
25. Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex.
Zhou W; Wang N; Yang C; Li XM; Zhou ZQ; Yang JJ
Eur Psychiatry; 2014 Sep; 29(7):419-23. PubMed ID: 24321772
[TBL] [Abstract][Full Text] [Related]
26. Validation study of microRNAs previously associated with antidepressant response in older adults treated for late-life depression with venlafaxine.
Marshe VS; Islam F; Maciukiewicz M; Fiori LM; Yerko V; Yang J; Turecki G; Foster JA; Kennedy SH; Blumberger DM; Karp JF; Kennedy JL; Mulsant BH; Reynolds CF; Lenze EJ; Müller DJ
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jun; 100():109867. PubMed ID: 31954757
[TBL] [Abstract][Full Text] [Related]
27. Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review.
du Jardin KG; Müller HK; Elfving B; Dale E; Wegener G; Sanchez C
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():27-38. PubMed ID: 27262695
[TBL] [Abstract][Full Text] [Related]
28. Comparison of rapid and long-lasting antidepressant effects of negative modulators of α5-containing GABA
Xiong Z; Zhang K; Ishima T; Ren Q; Chang L; Chen J; Hashimoto K
Pharmacol Biochem Behav; 2018 Dec; 175():139-145. PubMed ID: 30359627
[TBL] [Abstract][Full Text] [Related]
29. Intranasal administration of transforming growth factor-β1 elicits rapid-acting antidepressant-like effects in a chronic social defeat stress model: A role of TrkB signaling.
Wei Y; Chang L; Hashimoto K
Eur Neuropsychopharmacol; 2021 Sep; 50():55-63. PubMed ID: 33971385
[TBL] [Abstract][Full Text] [Related]
30. Role of Serotonin and Noradrenaline in the Rapid Antidepressant Action of Ketamine.
López-Gil X; Jiménez-Sánchez L; Campa L; Castro E; Frago C; Adell A
ACS Chem Neurosci; 2019 Jul; 10(7):3318-3326. PubMed ID: 31244055
[TBL] [Abstract][Full Text] [Related]
31. Cortical and raphe GABA
Pham TH; Defaix C; Nguyen TML; Mendez-David I; Tritschler L; David DJ; Gardier AM
Pharmacol Biochem Behav; 2020 May; 192():172913. PubMed ID: 32201299
[TBL] [Abstract][Full Text] [Related]
32. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
[TBL] [Abstract][Full Text] [Related]
33. Role of hippocampal p11 in the sustained antidepressant effect of ketamine in the chronic unpredictable mild stress model.
Sun HL; Zhou ZQ; Zhang GF; Yang C; Wang XM; Shen JC; Hashimoto K; Yang JJ
Transl Psychiatry; 2016 Feb; 6(2):e741. PubMed ID: 26905413
[TBL] [Abstract][Full Text] [Related]
34. The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice.
Lindholm JS; Autio H; Vesa L; Antila H; Lindemann L; Hoener MC; Skolnick P; Rantamäki T; Castrén E
Neuropharmacology; 2012 Jan; 62(1):391-7. PubMed ID: 21867718
[TBL] [Abstract][Full Text] [Related]
35. Sub-anesthetic doses of ketamine exert antidepressant-like effects and upregulate the expression of glutamate transporters in the hippocampus of rats.
Zhu X; Ye G; Wang Z; Luo J; Hao X
Neurosci Lett; 2017 Feb; 639():132-137. PubMed ID: 28043834
[TBL] [Abstract][Full Text] [Related]
36. Hippocampal MicroRNA-124 Enhances Chronic Stress Resilience in Mice.
Higuchi F; Uchida S; Yamagata H; Abe-Higuchi N; Hobara T; Hara K; Kobayashi A; Shintaku T; Itoh Y; Suzuki T; Watanabe Y
J Neurosci; 2016 Jul; 36(27):7253-67. PubMed ID: 27383599
[TBL] [Abstract][Full Text] [Related]
37. GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine.
Miller OH; Yang L; Wang CC; Hargroder EA; Zhang Y; Delpire E; Hall BJ
Elife; 2014 Oct; 3():e03581. PubMed ID: 25340958
[TBL] [Abstract][Full Text] [Related]
38. Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine.
Hashimoto K
Biochem Pharmacol; 2020 Jul; 177():113935. PubMed ID: 32224141
[TBL] [Abstract][Full Text] [Related]
39. Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine.
Dong C; Zhang JC; Yao W; Ren Q; Ma M; Yang C; Chaki S; Hashimoto K
Int J Neuropsychopharmacol; 2017 Mar; 20(3):228-236. PubMed ID: 27765808
[TBL] [Abstract][Full Text] [Related]
40. Calcium/Calmodulin-Dependent Protein Kinase II and Eukaryotic Elongation Factor 2 Kinase Pathways Mediate the Antidepressant Action of Ketamine.
Adaikkan C; Taha E; Barrera I; David O; Rosenblum K
Biol Psychiatry; 2018 Jul; 84(1):65-75. PubMed ID: 29395043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
